The right instrumentation can do wonders for the level of patient care you are able to deliver and the heights of profitability your practice is able to attain.
When I reflect on the evolution of my practice, one of the most significant milestones was the addition of the Optovue Solix in late 2019.
The decision to integrate this advanced technology was driven by a clear goal: to explore the benefits of Optical Coherence Tomography Angiography (OCT-A).
Looking back, I can confidently say that this investment has not only enhanced patient care, but also positively impacted our practice’s profitability and efficiency.
Let me share a compelling patient story that illustrates the transformative power of the Optovue Solix. I had a patient with a history of treated hypertension who was beginning to show signs of hypertensive retinopathy.
During our examination, we utilized the OCT-A, which revealed a surprising amount of retinal nonperfusion. This finding prompted me to delve deeper into the patient’s medication adherence, and to my surprise, he admitted he hadn’t been taking his prescribed medication.
This moment was pivotal. The OCT-A provided me with critical insights into the changes in vessel density that were consistent with untreated hypertension. It opened the door for a crucial conversation about his retinal changes and the importance of compliance with his treatment plan.
This is just one example of how Optovue Solix has empowered me to provide better care and foster meaningful discussions with my patients.
In terms of profitability, the Optovue Solix has proven to be a remarkable asset. It’s not every day that a single instrument generates hundreds of thousands of dollars in revenue, but Optovue Solix has done just that for our practice.
The financial metrics speak volumes about its impact on our bottom line, and it’s clear that this technology is not just a tool for diagnosis; it’s a revenue generator.
The Optovue Solix boasts several features that significantly improve patient care. Three standout capabilities include:
These features enhance patient outcomes and streamline our workflow, making our practice more efficient.
One of the standout aspects of the Optovue Solix is that it is the only OCT with FDA-cleared OCT-A metrics. This capability is crucial for measuring changes over time in various ocular diseases, including diabetic retinopathy, hypertensive retinopathy and glaucoma.
The ability to track these metrics enhances our patient care and supports our practice’s growth in both volume and profitability.
Optovue Solix’s multimodal imaging capabilities are another significant advantage. As our practice evolves, we need instruments that can grow with us.
The diverse tools available with Optovue Solix allow us to scale our utilization as we become more comfortable with its offerings. This adaptability is essential for maintaining a competitive edge in the ever-evolving field of optometry.
The introduction of the new CPT code 92137 for OCT-Angiography is crucial to maximizing profitability. While we are still navigating the reimbursement landscape, the potential for increased reimbursement for services we were already providing is a significant advantage.
As Medicare has yet to issue detailed guidelines for this code, we are actively working to optimize our billing processes to ensure we capture full financial benefits.
Ultimately, what makes the Optovue Solix invaluable is its dual benefit: it enhances patient care while simultaneously increasing practice revenues.
Early diagnosis leads to better patient outcomes, and having a tool like Optovue Solix allows me to provide superior care while significantly boosting our practice’s financial health.
Efficiency is another area where Optovue Solix shines. After analyzing our previous OCT processes compared to Optovue Solix, we found that our testing protocol efficiency increased by an impressive 30 percent.
This improvement is particularly significant in our main office, where we often have five optometrists practicing simultaneously. The ability to streamline workflows enhances patient satisfaction and allows us to serve more patients effectively.
In conclusion, the Optovue Solix has been a transformative addition to our practice. From enhancing patient care through early detection and comprehensive imaging to driving profitability and efficiency, this technology has exceeded our expectations.
As we continue to embrace advancements in optometry, I am excited about the future and the positive impact we can make in our patients’ lives.
If you’re considering integrating Optovue Solix into your practice, I wholeheartedly recommend it—it’s a decision you won’t regret.
This article originally appeared in Review of Optometric Business in Feb. 2025: https://reviewob.com/how-we-increased-our-eye-health-testing-protocol-efficiency-30/?hash=PmRRKFca69168
**Medical procedures, case studies, and practices mentioned in this content may vary based on regional standards, local regulations, and the discretion of providing healthcare professional. What may be considered appropriate and ethical in one country may differ in another.